Abstract:SUMOylation, which is a type of post-translational modification that involves covalent conjugation of small ubiquitin-like modifier (SUMO) proteins to target substrates, regulates various important molecular and cellular processes, including transcription, the cell cycle, cell signaling, and DNA synthesis and repair. Newly synthesized SUMO is immature and cleaved by the SUMO-specific protease family, resulting in exposure of the C-terminal Gly–Gly motif to become the mature form. In the presence of ATP, mature SUMO is conjugated with the activating enzyme E1 through the cysteine residue of E1, followed by transfer to the cysteine residue of E2-conjugating enzyme Ubc9 in humans that recognizes and modifies the lysine residue of a substrate protein. E3 SUMO ligases promote SUMOylation. SUMOylation is a reversible modification and mediated by SUMO-specific proteases. Cumulative studies have indicated that SUMOylation affects the functions of protein substrates in various manners, including cellular localization and protein stability. Gene knockout studies in mice have revealed that several SUMO cycling machinery proteins are crucial for the development and differentiation of various cell lineages, including immune cells. Aberrant SUMOylation has been implicated in several types of diseases, including cancers, cardiovascular diseases, and autoimmune diseases. This review summarizes the biochemistry of SUMO modification and the general biological functions of proteins involved in SUMOylation. In particular, this review focuses on the molecular mechanisms by which SUMOylation regulates the development, maturation, and functions of immune cells, including T, B, dendritic, and myeloid cells. This review also discusses the underlying relevance of disruption of SUMO cycling and site-specific interruption of SUMOylation on target proteins in immune cells in diseases, including cancers and infectious diseases.

The Function of SUMOylation and Its Critical Roles in Cardiovascular Diseases and Potential Clinical Implications

Role and mechanism of post-translational SUMOylation in atherosclerosis

SUMOylation as a Therapeutic Target for Myocardial Infarction

Function and regulation of ubiquitin-like SUMO system in heart

Cellular and molecular biology of posttranslational modifications in cardiovascular disease

SUMOylation in atherosclerosis

The Critical Roles of the SUMO-Specific Protease SENP3 in Human Diseases and Clinical Implications

Research progress on post-translational modification of proteins and cardiovascular diseases

Protein SUMOylation Modification and Its Associations with Disease

Involvement of activated SUMO-2 conjugation in cardiomyopathy.

The role and mechanism of SUMO modification in liver disease

Exosomes and Their Derivatives As Biomarkers and Therapeutic Delivery Agents for Cardiovascular Diseases: Situations and Challenges.

Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells

Protein Kinases in Cardiovascular Diseases

SUMOylation in Neurological Diseases

The emerging roles of SUMOylation in pulmonary diseases

Functional roles of exosomes in cardiovascular disorders: a systematic review.

Unravelling the molecular interplay: SUMOylation, PML nuclear bodies and vascular cell activity in health and disease

SUMOylation: A Link to Future Therapeutics.

Protein SUMOylation and disease

Unraveling the Intricate Roles of Exosomes in Cardiovascular Diseases: A Comprehensive Review of Physiological Significance and Pathological Implications